U.S. Stock News

NYSEAM:HYLN
NYSEAM:HYLNElectrical

Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist

The market has shown a positive trend, increasing by 1.7% over the last week and 20% over the past year, with earnings expected to grow significantly in the coming years. In such a climate, identifying stocks with strong financials becomes crucial for investors seeking opportunities beyond mainstream options. Penny stocks, despite their somewhat outdated moniker, remain relevant as investment choices due to their potential for growth and value when backed by solid fundamentals.
NYSE:ICE
NYSE:ICECapital Markets

How New Debt Raise And Pershing Square Stake At Intercontinental Exchange (ICE) Has Changed Its Investment Story

In August 2026, Intercontinental Exchange, Inc. completed several fixed-rate senior unsecured note offerings totaling about US$3.73 billion across maturities from 2029 to 2036, alongside reporting July trading volumes and open interest that were higher year over year across major asset classes. New interest from Pershing Square, which highlighted ICE’s entrenched exchange franchise and recurring, high-margin revenue model, underscores how institutional investors view the company as a core...
NasdaqGS:LMRI
NasdaqGS:LMRIHealthcare

Lumexa Imaging (LMRI) Stock Jumps As Profit Arrives But Margin Doubts Persist

Lumexa Imaging Holdings stock has been on a tear, rising about 73% over the past three months and adding another 4% in the first trading session after Q2 results. The market is leaning into a recovery story, yet the headline from this quarter is narrower. Lumexa finally printed a small GAAP profit alongside record free cash flow in a business that has been wrestling with losses. For an outpatient imaging operator that lives and dies by volume, mix and cash generation, the swing to US$2.7m in...
NYSE:KMX
NYSE:KMXSpecialty Retail

CarMax (KMX) Draws Law Firm Review Over Possible Shareholder Duty Breaches

CarMax (NYSE:KMX) is the subject of an ongoing investigation by an external law firm into potential breaches of fiduciary duty by its directors and officers. The review focuses on whether CarMax leadership met their obligations to shareholders and followed required governance standards. The investigation outcome could influence future corporate decisions and how some investors assess the company’s governance profile. This kind of governance spotlight is not unique to CarMax. It can be...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

Does SBAC’s 2026 Guidance And Capital Returns Change The Bull Case For SBA Communications?

SBA Communications recently reported its second-quarter 2026 results, showing year-over-year revenue growth but lower net income and earnings per share, while also updating full-year 2026 guidance to total revenues of US$2.84 billion to US$2.89 billion and net income of US$788.0 million to US$841.0 million. Alongside these results, the company affirmed its capital return focus with a US$1.25 quarterly dividend and completion of a US$400.0 million share repurchase program that retired...
NYSE:CLX
NYSE:CLXHousehold Products

How Investors May Respond To Clorox (CLX) 2027 Guidance Boosted By GOJO Deal And Dividend Hike

The Clorox Company recently reported that full-year 2026 net sales fell to US$6,720 million and net income to US$587 million, while issuing fiscal 2027 guidance calling for 13%–14% higher net sales and diluted EPS of US$5.41–US$5.71, helped by its GOJO acquisition. At the same time, Clorox’s board approved a small quarterly dividend increase to US$1.25 per share and management highlighted that most business lines are performing at or above expectations, suggesting that productivity...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

Balchem (BCPC) Q2 Results Raise The Question Of Whether The Stock Is Fully Valued

Balchem (BCPC) is back in focus after its second quarter 2026 report on July 31, which showed higher sales, net income and earnings per share compared with the same period a year earlier. See our latest analysis for Balchem. Balchem’s share price is US$177.14 after a small pullback over the past week. A 30 day share price return of 10.12% and a year to date gain of 15.01% suggest building momentum, supported by stronger quarterly results and the recent buyback update. The 1 year total...